Printed Diagnosis on Grey Background with Blurred Text and Composition of Pills, Syringe and Stethoscope

Bacterials and viral sexually transmitted infections (STIs) are a major global health problem. STIs can cause a wide range of symptoms and diseases to adults and children born of infected mothers. Many STIs also interact with HIV in multiple ways. STIs often enhance HIV acquisition and transmission risks whereas STIs acquisition and disease progression can be increased among people leaving with HIV, accelerating the spread of each other. STI control strategies typically rely on primary prevention, STI diagnosis, case management and treatment. Currently, only a few vaccines effectively protect against the acquisition of STIs (e.g. HPV and hepatitis B) there is a definite need for new STI vaccines to help future prevention efforts.

The STIs research in the department spans a wide range of activities with the overarching aim to improve STIs control. Our research focuses on

  • Natural history of STIs and their interaction with HIV
  • Quantifying burden of infection and disease 
  • Design and evaluation of STIs prevention interventions and treatment
  • Understanding for the epidemiology of STIs
  • Vaccine development and assessment of vaccination programmes
  • Antibiotic resistance 
  • Patient experience and health services
  • Sexual networks and molecular epidemiology

We have a particular focus on chlamydia, HPV, HSV-2, and gonorrhoea infection in the UK, Europe, US, Canada, as well as low and middle-income countries. We use a range of methods including development of theoretical framework, field epidemiological studies, mathematical modelling, systematic reviews, statistical analysis, and economic evaluations.

Academic staff